The bidirectional Thymus-Gut Axis: redefining central tolerance in digestive autoimmunity

Molecular Medicine · Published 2026-08-03 · DOI 10.1186/s10020-026-01588-0

Free full text

Authors (3)

Shiming Zhou, Mingxin Zhang, Yang Yang

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2026

Citation

Zhou, S., Zhang, M., Yang, Y. (2026). The bidirectional Thymus-Gut Axis: redefining central tolerance in digestive autoimmunity. Molecular Medicine. https://doi.org/10.1186/s10020-026-01588-0

Related articles

• Integrative machine learning and CRISPR/Cas9 analysis reveals the role of APOE in lipid metabolism–associated kidney fibrosis · Molecular Medicine · 2026 · Same journal
• ACL injury reprograms quadriceps myonuclear epigenetic and transcriptional signatures in mice · Molecular Medicine · 2026 · Same journal
• PRMT5 promotes psoriatic inflammation through mediating dimethylation of p65 in keratinocytes · Molecular Medicine · 2026 · Same journal
• O-GlcNAcylation: the metabolic-immune translator in tumor evolution and treatment · Molecular Medicine · 2026 · Same journal
• Prevalence of heterozygous and homozygous 9p21 deletions in human cancer: a tissue microarray study on 4,999 tumors from 125 different tumor types · Molecular Medicine · 2026 · Same journal
• From clinical suspicion to molecular detection of low-level mosaicism in NF2-related schwannomatosis via ultra-sensitive duplex sequencing · Molecular Medicine · 2026 · Same journal
• Immunogenic implications of translational readthrough modulate the association of F8 nonsense mutations with inhibitors in Hemophilia A · Molecular Medicine · 2026 · Same journal
• Secretory leukocyte protease inhibitor (SLPI) attenuates TLR4/NF-κB-mediated neuroinflammation in amyotrophic lateral sclerosis: a candidate molecule associated with neuro-pathology · Molecular Medicine · 2026 · Same journal
• Targeting Cathepsin B with p-coumaric acid rescues WWP1-dependent proteasomal degradation of NLRP3 in hyperuricemic nephropathy · Molecular Medicine · 2026 · Same journal
• Bispecific antibody AP402 targets p95HER2 and induces costimulation through CD137 to improve efficacy for HER2-positive tumors · Molecular Medicine · 2026 · Same journal